A Trial of Academic Detailing to Promote Prescribing of Biosimilars (NCT07221890)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions it aims to answer are: 1. Do educational outreach visits lead to a higher number of prescriptions for biosimilar versions of adalimumab? 2. Do in-person or virtual visits work better? Researchers will compare clinicians offered the educational outreach visit to those who are not offered the visit to see if there is a difference in prescribing of biosimilar versions of adalimumab instead of the original brand-name version. Participants will be offered the chance to meet with a trained clinician who will provide educational information tailored to their knowledge and attitudes on the topic. They will also be provided an educational brochure and patient educational materials.
Who can join: Review the eligibility criteria below.
Location: Humana Healthcare Research, Inc. — Louisville, Kentucky
🧪 Interventions in This Study
- Offered an academic detailing session (OTHER)
- Standard-of-care outreach from the insurance plan (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Humana Healthcare Research, Inc. — Louisville, Kentucky
- Brigham and Women's Hospital — Boston, Massachusetts
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Autoimmune Diseases
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry — Durham, North Carolina
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions — Culver City, California
- Deciphering the Genetic Architecture of Autoimmune Diseases — Bethesda, Maryland
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease — Orange, California
- VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems — Louisville, Kentucky
Explore by condition: All Autoimmune Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.